'vein2 improved patient outcomes'

Based on Mindray’s continuous innovation in hematology field, BC-5130 is especially tailored to assist diagnostic labs who need full CBC + 5-part results, with relatively low daily sample volume, restricted lab space and tight budget. As the lightest and most compact 5-part hematology analyzer so far from Mindray, BC-5130 is a highly user-friendly and innovative analyzer that offers cost efficient CBC and 5-part white cell differential results. It is targeted to fulfill and exceed the demands of our global customers by providing more accurate, more efficient and more innovative solutions for labs. Improved DC impedance technology is used to count and size the RBC and PLT. The smaller counting aperture (50 μm in diameter) provides better performance on samples with low PLT. Efficient Only three routine reagents are required. These have 2 years shelf life and also less consumed by BC-5130. Original QC and calibrator are also provided to ensure the hematology analyzer’s traceability and testing quality. WBC 5-Part differentiation,25 reportable parameters & 23 research parameters,3 histograms Whole blood Mode, Capillary whole blood mode & Prediluted Mode Tri-angle Laser Scatter + Chemical dye + Flow cytometry technology Dedicated optical counting channel for Basophil measurement 10.4 inch large TFT touch screen with user-friendly software Large storage capacity: Up to 1,50,000 samples Throughput:60 samples/Hour Compact Two kinds of lyse reagents are located inside of BC-5130, which helps the small labs to save space. BC-5130, the 5-part hematology analyzer offers a great solution for clinical labs, especially for those who have limited space. Its compact foot-print is a result of innovative technology improvements, including miniaturized semi-conductor laser source, highly integrated electronic boards and optimized liquid handling system. BC-5130 inherits it’s convenient and proven powerful software design from BC-6800 and BC-3600 platforms, the friendly interface is ideal for small sized labs. Running capillary blood through the sample probe directly is more convenient for the users in children’s hospitals, etc. For Prediluted mode, BC-5130 has higher dilution ratio than other 5-part hematology There’s NLR parameter in each CBC+DIFF result. Neutrophil-to-lymphocyte ratio (NLR) is calculated by dividing neutrophil count by lymphocyte count, usually from peripheral blood sample. In laboratory medicine, NLR is used as a marker of subclinical inflammation. According to clinical studies, NLR can be used as a prognostic factor of severe illness in COVID-19 patients. BC-5130 supports bi-directional LIS with test results and patient information. HL7 protocol is supported as well. Technology Compared with traditional helium neon laser or argon laser, semi -conductor laser has smaller size, lower cost and longer life cycle.

The BC-5390 is a 5-part Auto Hematology Analyzer that delivers high productivity, better accuracy and improved patient care, without sacrificing your budget. The analyzer utilizes the power of three mainstream technologies: laser scatter, flow cytometry, and chemical dye, to provide more accurate clinical information. The BC-5390 has been approved by FDA. Features Robust capacity and functionality Its throughput of 60 samples per hour saves your time, and the capacity of 40 autoloading tubes can extend your walk-away time. More reliable test result.The new reagent, with better anti-aging capacity, helps better differentiate Eosinophils from Neutrophils in the DIFF scattergram, even on samples with high density of Eosinophils. The analyzer is empowered by the fluid sensing technology to detect clot, bubble and insufficient sample, ensuring accurate sample aspiration. Flexible sample aspiration With different holder adapters, the analyzer supports three analysis modes - venous whole blood mode, pre-diluted mode and capillary whole blood mode. Product Specification Model Name/Number BC-5390 Operation Mode Fully Automatic Usage/Application Hospital Brand Mindray Capacity 40 autoloading tubes Throughput 60 samples per hour

Since the company was founded, Mindray has been continuously exploring new ways to improve diagnostic confidence. Powered by the most revolutionary ZONE Sonography® Technology, Resona 7’s new ZST+ platform brings ultrasound image quality to a higher level by zone acquisition and channel data processing. As well as the premium level image quality, Resona 7 also enhances clinical research capabilities with the revolutionary V Flow for vascular hemodynamic evaluation, and the most intelligent plane acquisition from 3D datasets for fetal CNS diagnosis. Combining the most intuitive gesture-based multi-touch operation and all the essential clinical features, Resona 7 is truly leading new waves in ultrasound innovation. With core platform advantages of ZST+ The channel data based ZST+ is an extraordinary innovation, representing an ultrasound evolution. Transforming ultrasound metrics from conventional beamforming to channel data based processing, ZST+ is able to deliver multiple imaging advances: Advanced Acoustic Acquisition, Dynamic Pixel Focusing, Sound Speed Compensation, Enhanced Channel Data Processing and Total Recall Imaging. Advanced features V Flow V Flow (Vector Flow) is a novel approach for vascular hemodynamic analysis. V Flow uses color coded vector arrows to indicate the velocity’s magnitude and direction of blood cells. With ultra-high frame rates, it provides extremely accurate and angle-independent visualization of complex vascular hemodynamic profiles. With comprehensive data information, V Flow is the most valuable tool for vascular clinical research. resona-7-fig3-1-pc UWN+ Contrast Imaging UWN+ (Ultra-Wideband Non-linear Plus) CEUS enables the Resona 7 to detect and utilize both the 2nd harmonic and non-linear fundamental signals, generating significantly enhanced images, resulting in greater sensitivity of minor signals and longer agent duration with lower MI. Forwarding smart to clinical intelligence The Resona 7 elevates clinical intelligence with a complete solution that enables clinicians to manage both routine and advanced studies more efficiently,consistently, and accurately, from acquisition to calculation. As an example, Smart Planes CNS shows exceptional intelligence in accurate diagnosis and analysis of the fetal central nervous system (CNS) Smart Planes CNS Mindray’s exclusive pioneering technology positions the Resona 7 as the industry’s first ultrasound system to allow fully automatic and accurate detection of the most significant planes and frequently used measurements of fetal CNS, leading to intelligent diagnosis, improved throughput, and reduced user dependence. Smart Planes CNS provides a user-friendly tool that greatly improves scanning efficiency through increased accuracy coupled with automated operation. With a simple button click on a 3D fetal brain volume image, the standard CNS scanning planes (MSP, TCP, TTP and TVP) and a range of related anatomical measurements (BPD, HC, OFD, TCD, CM and LVW) are obtained immediately. Smart Face Acquiring an optimal view of the fetal face in 3D ultrasound is cumbersome and time-consuming. In some cases, it is impossible to get rid of the occlusions such as cord, placenta, uterus and extremities. The new Resona 7 with Zone Intelligence provides a fast and intelligent optimization for fetal face with simply one-touch. It can immediately remove occlusions in the volume data, eliminate unwanted noise information, and generate an optimal view of the fetal face with minimal effort. Ergonomics The Resona 7 is designed around you. Gesture-based operation opens up a new trend in cart-based ultrasound with an agile, smart, and intuitive user experience beyond your expectations. Gel warmer’s three level temperature and swiveling angle adjustment of the control panel delivers great patient comfort and user convenience.

In compliance with out-of-hospital patient transport standards such as EN1789, EN13718-1, IEC60601-1-12 and U.S. military standards, N1 is a highly competent solution for various out-of-hospital transport settings both on land and in air. The N1's exceptional reliability and strong performance enhance your confidence to provide seamless patient care during transport no matter intra or out of hospital. One monitor, Multiple solutions Mirror Mode Two-way screen or remote control functionality and viewing on both the 19" external display and the N1 unit - simultaneously. benevision-n1-fig2-2-pc BeneVision N1 as a Transport Monitor Enhanced data analysis greatly improves parameters' accuracy and anti-interference ability. Its fully integrated sidestream CO2 module monitors the patient's breathing situation by connecting with sampling line directly, freeing caregivers from the shackles of expanding external modules for transport. One monitor, Multiple solutions Mirror Mode Two-way screen or remote control functionality and viewing on both the 19" external display and the N1 unit - simultaneously. benevision-n1-fig2-2-pc BeneVision N1 as a Transport Monitor Enhanced data analysis greatly improves parameters' accuracy and anti-interference ability. Its fully integrated sidestream CO2 module monitors the patient's breathing situation by connecting with sampling line directly, freeing caregivers from the shackles of expanding external modules for transport. benevision-n1-fig2-1-pc BeneVision N1 as a Multi-Parameter Module Slide directly into the module slot or SMR of the N-Series monitor providing an expansive set of parameter measurements. When combined with our additional advanced parameter modules, this solution fits even the highest level of critical care environments. benevision-n1-fig2-3-pc Companion Mode Connect with N-Series host monitor via cable connection to N1 dock and have the ability for dual-screen monitoring and bi-directional control of the bedside monitor - expanding slot space for more advanced parameters and enhanced ICU workflow. Patient-Centric Data Collection When connected to a bedside patient monitor, advanced parameters collected from the host monitor such as AG and BIS, etc., will also be stored in N1 with trend data and alarm events reviewable even when it is disconnected.

With state-of-the-art screen technology, BeneVision N Series patient monitors deliver clear, multi-color, wide-format displays for users to capture and review information at a glance. With multi-touch operation, users can control the monitor and review patient data quickly and easily. BeneVision N Series provides the world's best monitoring technologies for you, with new applications being developed. Perfect hemodynamic monitoring solution, not only provides a variety of measurement methods, ICG, PiCCO, ScvO2, C.O., but also provides comprehensive analysis tool – HemoSight™. HemoSight™ focuses on hemodynamic treatment process, and provides appropriate tools for each stage. Advanced modular regional tissue oxygenation measurement -- INVOS rSO2. Volumetric capnography & metabolic measurement help to evaluate the adequacy of ventilation and determine the ventilator setting effectively, and improve the safety of weaning and extubation. Powerful Clinical Assistive Applications (CAAs) to support efficient decision making when time is critical. Each CAA focuses on major clinical workflow challenges that individual departments face. Solutions optimized for each point of care At every point of care, such as ICU, CCU, NICU, OR, PACU, ER, BeneVision N Series patient monitors always provide a suitable solution to meet your clinical needs for monitoring your patient's status anywhere, anytime, even on your way through mobile devices. With excellent transport solution, BeneVision N Series patient monitor brings a smooth workflow and safe data management through the entire care process. BeneVision takes less time to operate, and helps you understand the patient's variables quickly. With HL7,BeneVision N Series patient monitors can directly connect to the hospital clinical network.BeneVision N12 is capable of monitoring multiple parameters simultaneously both at bedside and during transport. IT structure designed for seamless connectivity Mindray patient monitoring system incorporates extensive network adaptability to integrate with the hospital's current network infrastructure, ensuring that critical data is on hand for clinical decision making - and is integrated with the patient record. Mindray's central station and eGateway further enhances the connectivity of BeneVision to your clinical world. Bedside devices data and other clinical systems data are shared to support your diagnosis and clinical decisions.

Mindray believes the best way to predict the future is to create it. The revolutionary BeneVision N22/N19 is designed to optimize user experience by satisfying all your clinical demands. With visionary-stimulating design, benchmarking ease of use, confidence-maximizing innovations and workflow-transforming interoperability, BeneVision N22/N19 is creating tomorrow’s monitoring perspective today. The design excellence of BeneVision N22/N19 has great originality to lead your perspective. A seamless outlook optimizes your monitoring experience with super large touchscreen, cool rotatable landscape & portrait layout, ultra slim main unit as well as plug-n-play modules. An ingenious user interface including multi-window flat menus, infographic alarm indications and online user guide offers extremely intuitive patient data and ultimate ease-of-use, while auto screen brightness always keeps patient in mind. Benefitting from cutting-edge clinical measurements, such as rSO2, ICG, PiCCO, AG, RM, BIS, NMT, and state-of-art clinical decision support tools, such as HemoSightTM, ST GraphicTM, DSA, BeneVision N22/N19 enhances your clinical confidence to the max and helps you make easier and faster clinical decisions. The connectivity capabilities of BeneVision N22/N19 fit seamlessly into your clinical workflow for paperless future. Revolutionary iView clinical informatics workstation brings all intelligence (PACS, LIS, EMR, etc) on screen at point of care for one-stop diagnosis. Industry-leading BeneLink integrates all bedside devices to the monitor realtimely and facilitates centralized data management.

The ADAMS A1c, HA-8180 is a fully automated Glycohemoglobin (HbA1c) analyzer based on HPLC (High Performance Liquid Chromatography). HbA1c is a good parameter for long-term blood glucose monitoring in patients suffering from diabetes mellitus. Measurement Speed: 48 sec/test for Fast Mode and 90 sec/test for Variant mode. Measurement items are as follows. HA-8180V, Fast Mode HbA1c (Stable HbA1c, S-A1c) and HbF HA-8180V, Variant Mode　 HbA1c (Stable HbA1c, S-A1c) and HbF HbS and HbC separation and HbE and HbD detection can be performed. ・Column design with no more pre-filter change ・Economical - improved aluminium reagents for more efficient reagent supply ・Color LCD with reagent level, graphs on screen Specifications Configuration Main body, sampler (with sample tube spinning unit) and accessories Measurement objects Whole blood or hemolysis sample Column COLUMN UNIT 80 Reagents ELUENT 80A, ELUENT 80B, ELUENT 80CV and HEMOLYSIS WASHING SOLUTION 80H Measurement items Fast Mode HbA1c (Stable HbA1c, S-A1c) and HbF Variant Mode HbA1c (Stable HbA1c, S-A1c) and HbF (HbS and HbC separation and HbE and HbD detection can be performed) Measurement ranges *1 HbA1C: 3 - 20%, 9 - 195 mmol/mol HbF: 0 - 100% Guaranteed measurement ranges *2 HbA1C: 4 - 16%, 20 - 151 mmol/mol HbF: 0.3 - 5% Measurement principle Reversed-phase cation exchange chromatography Measurement wavelength 420 nm / 500 nm (Dual-wavelength colorimetry) Sample supply Sampler Resolution 0.1 % Ratio, 1 mmol / mol Processing speed Variant mode : 90 seconds / test Fast mode : 48 seconds / test Sample consumption Approximately 14 μL (Whole blood) Required sample volume Sample tube : Minimum 10 mm away from the bottom Sample cup : 400 μL or more Sample container Sample tube : (12.3/15 mm diameter) × (75 to 100 mm length) Sample cup: 500 μL Compatible rack type ARKRAY racks Number of measurement samples One-way transportation (factory-set) : Maximum 50 samples Loop transportation : Maximum 100 samples Column temperature Approximately 40°C Warm-up time Maximum 30 minutes Display Large color LCD with backlight Printer For use with 58-mm width thermal printer paper Memory capacity 900 measurement results (including calibration results) External output Serial 1 port (Can be optionally used as an Ethernet port.) Communication system RS-232C compliant (Switchable between one-way and two-way communications.) Transmission speed RS-232C : Selectable from 300, 600, 1200, 2400, 4800, 9600 and 19200 bps Ethernet: 10BASE-T Dimensions 530 (W) × 530 (D) × 530 (H) mm (Not including the hemolysis washing solution bottle) Weight Main body: Approximately 39 kg, Sampler: Approximately 4 kg Power requirements 100 - 240 V AC ± 10 %, 50 / 60 Hz Power input Maximum 300 VA *1 Error-free measurement ranges *2 Guaranteed ranges for obtaining results equivalent to those from HA-8160 VP mode measurement

Abbott FreeStyle Libre 3 FreeStyle Libre 3 System Next-Gen CGM performance you can count on Now with the smallest, thinnest1 and most discreet2 sensor yet Readings3 are updated 5x faster than other CGMs4 Outperforms other CGMS in connectivity5 Unsurpassed 14-day accuracy, especially in the low glucose range6 Optional, real-time glucose alarms let patients know the minute their glucose is too low6 Performance you can count on With a CGM system that sends real-time glucose readings every minute directly to your patients' smartphones,7 they will be ready to avoid hypos Unsurpassed accuracy 9.2% Overall MARD6 (Adults) and Unsurpassed 14-day accuracy, especially in the low glucose range6 with 93.2% within ±20/20% of YSI values for glucose levels <80 mg/dL and ±20% when ≥80 mg/dL6. No data gaps Now the sensor can store data up to 14 days. So no data gaps means your patients can always retrieve their data even when their smartphone has not synced with their sensor for up to 14 days. Proven clinical outcomes A1c was reduced by 0.55% at 2 to 4 months and sustained for 12 months8 and 50% reduction in serious hypoglycaemia (≤54 mg/dL).9

INTENDED USE The Finecare™ HbA1c Rapid Quantitative Test is a fluorescence immunoassay used along with Finecare™ FIA System for quantitative determination of Hemoglobin A1c in human blood. The test is used as an aid to monitor long-term glycemic status in patients with diabetes mellitus. STORAGE AND STABILITY 1. Store the test kit at 4℃~30℃ up to the expiration date printed on package. 2. If removed from refrigerator, allow the test kit for 30 minutes to return to room temperature before testing. 3. Do not remove the Test Cartridge from the pouch until use. The Test Cartridge should be used within 1 hour once opened.